Funding
Funding not disclosed
Founders
Product
Problem
Post‑operative wound healing can be slow and prone to complications, leading to extended hospital stays and delayed patient recovery. Limited options exist for actively supporting tissue repair at the surgical site.
Solution
Sustain Surgical is developing the “S” medical device, a surgical adjunct designed to enhance tissue healing and accelerate recovery after operative procedures. The device is intended to be applied directly to the wound site, providing a supportive environment that promotes cellular regeneration and reduces inflammation. By integrating biocompatible materials and controlled‑release therapeutics, the “S” aims to improve closure strength and shorten healing timelines. The solution is positioned for use in a range of surgical specialties, enabling clinicians to deliver faster, more reliable outcomes for patients.
Target Audience
Primary customers are surgeons and hospital systems performing elective and emergency surgeries that require enhanced wound management.
Features
- Biocompatible scaffold that conforms to diverse wound geometries
- Controlled release of growth factors or anti‑inflammatory agents to stimulate regeneration
- Easy intra‑operative application with standard surgical instruments
- Designed for compatibility with existing suturing and closure techniques
- Resorbable material that safely degrades as native tissue remodels